Company intelligence / Profile preview

Biospring Partners

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Biospring Partners is not a therapeutics developer but a growth equity firm investing in technology-enabled, EBITDA-positive B2B pharma services and life sciences technology companies, particularly in outsourced complex biomanufacturing and clinical trial services.[1][2][3][4]

Industry: Investors

Beyond the preview

Go deeper on Biospring Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biospring Partners.

Explore the full profile